About the Diabetes and Obesity Center
Our scientists seek to explore the metabolic basis of disease and to rapidly translate discovery to clinical care by leveraging the bridges we have built with clinical partners.
- Daniel Kelly, M.D.
Senior Vice President and Scientific Director, Tavistock Distinguished Professor, Sanford-Burnham at Lake Nona
Type 2 diabetes, which is driven by obesity, has increased dramatically in the last decade, with more than 60 percent of U.S. adults diagnosed as overweight or obese. To address these challenges, scientists in the Diabetes and Obesity Research Center are studying the metabolic basis of obesity-related diabetes and its cardiovascular complications. The center is focused on translational research and has established advanced technology resources and formed clinical and pharmaceutical research partnerships to drive their discoveries toward patient application. Read on to learn more about our
drug discovery capabilities, and
shared resources, or visit
our blog for frequent updates.
Learn more about our diabetes and obesity research in the following fields: